Navigation Links
US Cancer Pain Market to Reach $5 Billion by 2018 - Cancer Patient Growth Drives Value
Date:2/3/2009

SAN FRANCISCO, Feb. 3 /PRNewswire/ -- The US market for the drug treatment of cancer pain in 2008 is valued at $3.1 billion, according to US Cancer Pain, a report released today by WWMR, Inc. The cancer pain market is dominated by opioid drugs, a trend expected to continue throughout the next decade. The increasing number of cancer pain patients will be the primary driver of market value during the forecast period.

Few of the many drugs in development for pain conditions are seeking regulatory approval for cancer pain. Of these, most are reformulations of fentanyl or other opioids, using novel delivery devices or as combination therapies. Reformulations of existing opioids are unlikely to capture market share unless they can compete economically with older agents that are already available on payer-approved formularies.

Today, half of the 4.1 million cancer patients in the US experience pain. More than 600,000, among these, experience moderate-to-severe pain. WWMR estimates that the cancer pain market will be valued at $5.3 billion in 2018, based on a patient population of more than 2.5 million cancer pain patients. While most pain is the result of tissue damage caused by the tumor, some cancer pain is due to the effects of chemotherapy, radiation or surgery; moreover, 25% of patients experience more than one type of cancer pain.

WWMR provides estimates for 2008 and projections to 2018 for SEVEN types of cancer pain: tumor-related, treatment-related, neuropathic, breakthrough pain, malignant bone pain, visceral pain and soft-tissue pain. Interviews with oncologists and pain clinicians, as well as data from WWMR's US Pain Clinic Monitor provide additional perspective on the cancer pain market. WWMR's US Pain Clinic Monitor is an audit of more than 100 pain clinics that includes prescribing data on cancer pain and 26 other pain indications.

Worldwide, only 25 agents are in active cl
'/>"/>

SOURCE WWMR, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Prayers From Maria - Childrens Glioma Cancer Foundation Hosts Sunflower Soiree
2. NCCN Updates Breast Cancer and Breast Cancer Risk Reduction Guidelines
3. Polymedco Introduces New Colorectal Cancer Educational Website
4. Stool-Based Colon Cancer Tests Vary Widely in Accuracy
5. UCLA scientists develop crystal ball for personalized cancer treatment
6. Workforce shortages in mammography could threaten early detection rates for breast cancer
7. Inflammation in colon may get doused before fueling cancer development
8. New Clues to Stopping Colitis-Linked Cancer
9. 2 immune-system proteins linked to colitis-associated cancer
10. PET/CT may improve prognosis for patients with inflammatory breast cancer
11. Top Belgian Cancer Center Becomes First in Country to Introduce RapidArc Radiotherapy Treatments From Varian Medical Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2015)... 18, 2015 More than 2000 styles ... at TheCelebrityDresses.com, the #1 online store carrying celebrity inspired ... girls have got their perfect dresses for their prom. ... fashion prom dresses at TheCelebrityDresses.com would be an ideal ... than 2000 prom dresses inspired by the most loved ...
(Date:4/18/2015)... 2015 French physician and gastronome Anthelme ... when he uttered, “Tell me what you eat, and ... to cope with stress or sadness has often been ... indicates otherwise. Data collected from their Emotional Eating ... emotional eating, but for different reasons. , Collecting data ...
(Date:4/17/2015)... California (PRWEB) April 17, 2015 ... Dr. Kevin Sadati of the Gallery of ... Orange County’s top beauty experts. The publication focused ... lift, facial stem cell fat grafting, eyelid surgery, laser ... facial plastic surgery has resulted in thousands ...
(Date:4/17/2015)... April 17, 2015 In Defense of ... following statement: “On Wednesday April 15th, the European Parliament ... a resolution recognizing the Armenian Genocide, “paying tribute, on ... the one-and-a-half million innocent Armenian victims who perished in ... extols the EU for this timely and needed recognition ...
(Date:4/17/2015)... Hollywood, California (PRWEB) April 17, 2015 ... Durkin Entertainment’s EcoLuxe Lounge and the “Salute to the ... the luxurious Beverly Hilton Hotel, overlooking the impressive Los ... nominees were organized by Debbie Durkin, LA’s leading producer ... , Showcasing many of the world’s premier providers of ...
Breaking Medicine News(10 mins):Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 3Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 4Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 6Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 2Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 3Health News:In Defense of Christians Condemns Armenian Genocide 2Health News:In Defense of Christians Condemns Armenian Genocide 3Health News:Choices Recovery Speaks with Dakota Hood of “The Hunger Games” about Addiction in Hollywood 2
... SEGUNDO, Calif., Feb. 4 Better Nutrition,( http://www.betternutrition.com ... announced today the winners of their "Best of ... natural products industry, this,program recognizes outstanding beauty products ... Facial Cleansers: Derma E Organic Expressions, ...
... has,agreed to settle for $2.5 million, plus interest, ... program, the Justice Department,announced today. The settlement is ... Medical Center is currently in bankruptcy., The ... to Medicare patients in order to obtain enhanced,reimbursement ...
... The President,Medicine & Science, American Diabetes Association, John ... response to the Bush Administration,s,proposed Fiscal Year 2009 ... research and prevention at the National Institutes of,Health ... Prevention (CDC).,Under the Administration,s budget proposal, funding for ...
... Nation, BOUND BROOK, N.J., Feb. 4 ... consider, among other,issues, a Presidential candidate,s position on ... to a universal healthcare,plan has been in effect ... than other U.S. states for health insurance on ...
... Feb. 4 ATS Medical, Inc.,(Nasdaq: ATSI ... and services, today provided preliminary revenue results,for the ... 2007., (Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO ), The ... 2007 to be,approximately $14.2 million, which would represent ...
... is also a Champion for Babies, NEW YORK, Feb ... NY Giants Quarterback, Eli Manning, will serve as the,official Celebrity ... as WalkAmerica, March for Babies is the March of Dimes,premier ... those who need help to survive and thrive., "I,m ...
Cached Medicine News:Health News:Better Nutrition Announces 'Best Of Beauty Awards' Winners Showcasing the Best Natural Beauty Products of 2008 2Health News:Buyer of Bayonne Hospital to Pay U.S. $2.5 Million to Resolve Allegations of Medicare Fraud 2Health News:Statement of the American Diabetes Association on the Administration's Proposal to Undermine Funds for Research, Prevention and Treatment in FY09 2Health News:NJ Voters Take Heed: Be Wary of Presidential Candidates Touting Universal Healthcare 2Health News:NJ Voters Take Heed: Be Wary of Presidential Candidates Touting Universal Healthcare 3Health News:ATS Medical Expects Fourth Quarter Revenue to Increase by Approximately 32% 2Health News:Eli Manning Teams Up with March of Dimes in New York City 2
(Date:4/17/2015)... , April 17, 2015  Trovagene, Inc., (NASDAQ: ... today that clinical data presented at the 2015 ... urine-based Precision Cancer Monitoring ℠ (PCM) platform ... of EGFR T790M mutations in metastatic ... of EGFR T790M Mutation in Urinary Circulating Tumor ...
(Date:4/17/2015)... Research and Markets ( http://www.researchandmarkets.com/research/5hkm2f/medical_oxygen ) ... Systems - Global Strategic Business Report" report to ... markets for Medical Oxygen Systems in US$ Thousands by ... Cylinders & Regulators, and Oxygen Conserving Devices. The report ... Canada , Japan , ...
(Date:4/17/2015)... Today, the Pharmaceutical Research and Manufacturers ... biopharmaceutical companies as "We Work For Health Champions" ... community service. Established in 2009, the ... by the biopharmaceutical industry to honor employees who ... have also shown an outstanding commitment to their ...
Breaking Medicine Technology:Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4Medical Oxygen Systems - 2015 Global Strategic Business Report Featuring Leading Players, Caire, Invacare & Philips Respironics 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 3
... MAP,Pharmaceuticals, Inc. (Nasdaq: MAPP ) announced ... of Unit Dose Budesonide (UDB) for the potential,treatment ... that the clinical,trial did not meet its co-primary ... in nighttime and daytime composite symptom scores, in,either ...
... 23 BN,ImmunoTherapeutics, Inc. today provided updated data ... MVA-BN(R)-HER2, in development as,therapy of metastatic breast cancer ... primary endpoint with regards to safety and by ... response was,detected in approximately 70% of evaluated patients. ...
Cached Medicine Technology:MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints 2MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints 3BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine 2BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine 3
As pupil size continues to play a significant role in the outcomes of refractive surgery, the pre-operative use of the Colvard Pupillometer continues to be the standard of care for obtaining accurate...
Subretinal Injection Cannula, Curved; 20g (0.90) x 1" (25mm); Tip Extension: 3mm, 32g (0.23); Angled at 35°....
Silicone Oil Cannula; 16g (1.40) x 8mm....
...
Medicine Products: